Published in Mol Ther Nucleic Acids on November 29, 2016
Applications of CRISPR/Cas9 in retinal degenerative diseases. Int J Ophthalmol (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A (2008) 13.09
Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells (2009) 5.69
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature (2011) 4.92
Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med (1998) 3.77
Definition of an efficient synthetic poly(A) site. Genes Dev (1989) 3.68
Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med (2007) 3.36
Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells (2010) 3.24
Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res (2009) 2.74
Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science (1996) 2.05
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet (2002) 1.86
Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Mol Ther (2007) 1.76
Arginases I and II: do their functions overlap? Mol Genet Metab (2004) 1.67
In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Sci Transl Med (2011) 1.66
Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology (2012) 1.64
A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells. Cell Stem Cell (2016) 1.60
Genetic modification of human embryonic stem cells for derivation of target cells. Cell Stem Cell (2008) 1.56
Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics (2003) 1.49
Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS One (2009) 1.47
Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol (2010) 1.41
Genome editing of human pluripotent stem cells to generate human cellular disease models. Dis Model Mech (2013) 1.37
Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care (2010) 1.35
Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation (2003) 1.31
The incidence of urea cycle disorders. Mol Genet Metab (2013) 1.23
Hepatocyte transplantation for inherited factor VII deficiency. Transplantation (2004) 1.18
Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur J Pediatr (2003) 1.17
Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector. Mol Ther (2009) 1.10
Cell and tissue engineering for liver disease. Sci Transl Med (2014) 1.08
From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols. Stem Cells Transl Med (2011) 1.07
Contrasting features of urea cycle disorders in human patients and knockout mouse models. Mol Genet Metab (2007) 1.04
Expression of the lacZ gene targeted to the HPRT locus in embryonic stem cells and their derivatives. Transgenic Res (1993) 1.03
Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes. J Hepatol (2014) 1.03
Human embryonic stem cells and gene therapy. Mol Ther (2007) 1.02
Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy. Mol Ther (2012) 1.02
AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse. Gene Ther (2013) 0.97
Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice. Mol Ther (2014) 0.97
Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported? Mol Genet Metab (2011) 0.94
Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse. Mol Genet Metab (2013) 0.94
Rapid and efficient conversion of integration-free human induced pluripotent stem cells to GMP-grade culture conditions. PLoS One (2014) 0.94
Generation and genetic modification of induced pluripotent stem cells. Expert Opin Biol Ther (2010) 0.91
Hepatocyte transplantation followed by auxiliary liver transplantation--a novel treatment for ornithine transcarbamylase deficiency. Am J Transplant (2008) 0.90
Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects. Mol Genet Metab (2010) 0.88
Molecular basis of phenotypic variation in patients with argininemia. Hum Genet (1995) 0.87
Human embryonic stem cells: a potential source for cellular therapy. Am J Transplant (2004) 0.86
Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead. Mol Ther (2010) 0.86
Enriching CRISPR-Cas9 targeted cells by co-targeting the HPRT gene. Nucleic Acids Res (2015) 0.83
Minimal ureagenesis is necessary for survival in the murine model of hyperargininemia treated by AAV-based gene therapy. Gene Ther (2014) 0.82
Genetic analysis of human hypoxanthine-guanine phosphoribosyltransferase deficiency. Enzyme (1987) 0.78
Urea cycle disorders: a case report of a successful treatment with liver transplant and a literature review. World J Gastroenterol (2015) 0.77
Impact of immune response on the use of iPSCs in disease modeling. Curr Stem Cell Res Ther (2015) 0.76
Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells. Mol Ther Nucleic Acids (2016) 0.75